Yanchao Zhang, Nicole Wente, Stefanie Leimbach, Doris Klocke, Anne Tellen, Julia Nitz, Franziska Nankemann, Helen Louton, Volker Krömker
{"title":"In vitro capsule or biofilm formation of Streptococcus uberis and bacteriological cure of bovine mastitis.","authors":"Yanchao Zhang, Nicole Wente, Stefanie Leimbach, Doris Klocke, Anne Tellen, Julia Nitz, Franziska Nankemann, Helen Louton, Volker Krömker","doi":"10.1055/a-2410-1465","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The relationship between the <i>in vitro</i> detected virulence factors biofilm and capsule formation of <i>Streptococcus (S.) uberis</i> isolates of clinical mastitis in dairy cows and the bacteriological cure rate after antibiotic therapy was investigated in order to better understand the importance of these virulence factors for the bacteriological cure rate.</p><p><strong>Material and methods: </strong>A total of 111 clinical mastitis (CM) cases were collected, in which <i>S. uberis</i> was bacteriologically detected. All mastitis cases were treated in accordance with the approval conditions of the antibiotic udder tubes used. Individual cow information including age, number of lactations, current lactation mastitis and antimicrobial treatment received was recorded. The microtiter plate test was used to detect biofilm formation and Anthony capsule staining was used to detect capsular capacity. Statistical analyses were performed to characterize the correlation between <i>in vitro</i> virulence factors and bacteriological cure (BC) rate.</p><p><strong>Results: </strong>30.5% (n=29) of the <i>S. uberis</i> isolates of bacteriologically cured cases and 34.5% (n=10) of the isolates of bacteriologically non-cured mastitis cases were found to have the ability to produce capsules <i>in vitro</i>. 70.7% (n=58) of the <i>S. uberis</i> isolates from bacteriologically cured mastitis cases had the ability to produce biofilm <i>in vitro</i>, whereas 58.6% (n=17) of the isolates of non-cured mastitis cases showed ability in producing biofilm. No correlation was found between the <i>in vitro</i> ability of <i>S. uberis</i> to form capsules and biofilms and the BC rate after antibiotic treatment of bovine mastitis.</p><p><strong>Conclusion(s): </strong>The present work has shown that the investigated <i>in vitro</i> virulence factors are not associated with the BC after antibiotic therapy. Further studies on the role of <i>S. uberis</i> virulence factors are needed to complete the missing knowledge on the difficulties in curing <i>S. uberis</i> mastitis.</p><p><strong>Clinical relevance: </strong>This study is of great clinical relevance since it enhances the understanding of the occurrence of BC in <i>S. uberis</i> mastitis cases. The investigated virulence factors are often addressed as possible reasons for therapy failure, although respective scientific studies are missing.</p>","PeriodicalId":23115,"journal":{"name":"Tieraerztliche Praxis Ausgabe Grosstiere Nutztiere","volume":null,"pages":null},"PeriodicalIF":0.4000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tieraerztliche Praxis Ausgabe Grosstiere Nutztiere","FirstCategoryId":"97","ListUrlMain":"https://doi.org/10.1055/a-2410-1465","RegionNum":4,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/24 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"VETERINARY SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: The relationship between the in vitro detected virulence factors biofilm and capsule formation of Streptococcus (S.) uberis isolates of clinical mastitis in dairy cows and the bacteriological cure rate after antibiotic therapy was investigated in order to better understand the importance of these virulence factors for the bacteriological cure rate.
Material and methods: A total of 111 clinical mastitis (CM) cases were collected, in which S. uberis was bacteriologically detected. All mastitis cases were treated in accordance with the approval conditions of the antibiotic udder tubes used. Individual cow information including age, number of lactations, current lactation mastitis and antimicrobial treatment received was recorded. The microtiter plate test was used to detect biofilm formation and Anthony capsule staining was used to detect capsular capacity. Statistical analyses were performed to characterize the correlation between in vitro virulence factors and bacteriological cure (BC) rate.
Results: 30.5% (n=29) of the S. uberis isolates of bacteriologically cured cases and 34.5% (n=10) of the isolates of bacteriologically non-cured mastitis cases were found to have the ability to produce capsules in vitro. 70.7% (n=58) of the S. uberis isolates from bacteriologically cured mastitis cases had the ability to produce biofilm in vitro, whereas 58.6% (n=17) of the isolates of non-cured mastitis cases showed ability in producing biofilm. No correlation was found between the in vitro ability of S. uberis to form capsules and biofilms and the BC rate after antibiotic treatment of bovine mastitis.
Conclusion(s): The present work has shown that the investigated in vitro virulence factors are not associated with the BC after antibiotic therapy. Further studies on the role of S. uberis virulence factors are needed to complete the missing knowledge on the difficulties in curing S. uberis mastitis.
Clinical relevance: This study is of great clinical relevance since it enhances the understanding of the occurrence of BC in S. uberis mastitis cases. The investigated virulence factors are often addressed as possible reasons for therapy failure, although respective scientific studies are missing.
目的研究奶牛临床乳腺炎中分离的尤伯杯链球菌(S. uberis)体外检测到的毒力因子生物膜和胶囊形成与抗生素治疗后细菌学治愈率之间的关系,以更好地了解这些毒力因子对细菌学治愈率的重要性:材料和方法:共收集了 111 例临床乳腺炎(CM)病例,并对这些病例进行了细菌学检测。所有乳腺炎病例均按照所用抗生素乳房管的批准条件进行治疗。记录奶牛的个体信息,包括年龄、泌乳次数、当前泌乳期乳腺炎和接受的抗菌治疗。微孔板试验用于检测生物膜的形成,安东尼胶囊染色法用于检测胶囊能力。对体外毒力因子与细菌治愈率(BC)之间的相关性进行了统计分析:结果:30.5%(n=29)的细菌学治愈病例和 34.5%(n=10)的细菌学未治愈乳腺炎病例分离株具有体外产生胶囊的能力。在细菌学治愈的乳腺炎病例中,70.7%(n=58)的尤贝菌分离物具有体外产生生物膜的能力,而在未治愈的乳腺炎病例中,58.6%(n=17)的分离物具有产生生物膜的能力。在体外形成胶囊和生物膜的能力与牛乳腺炎抗生素治疗后的 BC 率之间没有发现相关性:本研究表明,所调查的体外毒力因子与抗生素治疗后的乳糜泻率无关。需要进一步研究乌贝氏菌毒力因子的作用,以填补在治疗乌贝氏菌乳腺炎的困难方面所缺失的知识:本研究具有重要的临床意义,因为它加深了人们对乌贝氏菌乳腺炎病例中 BC 发生情况的了解。尽管缺乏相应的科学研究,但所调查的毒力因素往往被视为治疗失败的可能原因。
期刊介绍:
Die Tierärztliche Praxis wendet sich mit ihren beiden Reihen als einzige veterinärmedizinische Fachzeitschrift explizit an den Großtier- bzw. Kleintierpraktiker und garantiert damit eine zielgruppengenaue Ansprache. Für den Spezialisten bietet sie Original- oder Übersichtsartikel zu neuen Therapie- und Operationsverfahren oder den Einsatz moderner bildgebender Verfahren. Der weniger spezialisierte Tierarzt oder Berufseinsteiger findet auf seinen Berufsalltag zugeschnittene praxisbezogene Beiträge in der Fortbildungsrubrik „Aus Studium und Praxis“. Mit dem hervorgehobenen „Fazit für die Praxis“ am Ende jedes Artikels verschafft sich auch der eilige Leser einen raschen Überblick über die wichtigsten Inhalte dieser modern konzipierten Fachzeitschrift mit den vielen hochwertigen, überwiegend farbigen Abbildungen. In jedem Heft ermöglicht ein ATF-anerkannter Fortbildungsartikel den Erwerb einer ATF-Stunde (Akademie für tierärztliche Fortbildung).